KOSSAN RUBBER INDUSTRIES BHD
KLSE (MYR): KOSSAN (7153)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
1.96
Today's Change
+0.02 (1.03%)
Day's Change
1.91 - 1.96
Trading Volume
2,106,100
Financial
Market Cap
5,013 Million
NOSH
2,558 Million
Latest Quarter
30-Jun-2024 [#2]
Announcement Date
22-Aug-2024
Next Quarter
30-Sep-2024
Est. Ann. Date
15-Nov-2024
Est. Ann. Due Date
29-Nov-2024
QoQ | YoY
-0.36% | 1,050.30%
Revenue | NP to SH
1,685,158.000 | 104,570.000
RPS | P/RPS
65.88 Cent | 2.98
EPS | P/E | EY
4.09 Cent | 47.94 | 2.09%
DPS | DY | Payout %
2.00 Cent | 1.02% | 48.80%
NAPS | P/NAPS
1.51 | 1.30
QoQ | YoY
49.53% | 1642.1%
NP Margin | ROE
6.38% | 2.71%
F.Y. | Ann. Date
30-Jun-2024 | 22-Aug-2024
Latest Audited Result
31-Dec-2023
Announcement Date
24-Apr-2024
Next Audited Result
31-Dec-2024
Est. Ann. Date
24-Apr-2025
Est. Ann. Due Date
29-Jun-2025
Revenue | NP to SH
1,585,878.000 | 14,222.000
RPS | P/RPS
62.00 Cent | 3.16
EPS | P/E | EY
0.56 Cent | 352.51 | 0.28%
DPS | DY | Payout %
2.00 Cent | 1.02% | 358.83%
NAPS | P/NAPS
1.50 | 1.31
YoY
-90.92%
NP Margin | ROE
1.08% | 0.37%
F.Y. | Ann. Date
31-Dec-2023 | 22-Feb-2024
Revenue | NP to SH
1,763,058.000 | 125,790.000
RPS | P/RPS
68.93 Cent | 2.84
EPS | P/E | EY
4.92 Cent | 39.86 | 2.51%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
-0.02% | 328.27%
NP Margin | ROE
7.28% | 3.27%
F.Y. | Ann. Date
30-Jun-2024 | 22-Aug-2024
Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.
Date
Financial Result
Financial Ratio
Per Share Item
Performance
Valuation (End of Quarter)
Valuation (Ann. Date)
| Date | Financial Result | Financial Ratio | Per Share Item | Performance | Valuation (End of Quarter) | Valuation (Ann. Date) | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| F.Y. | Ann. Date | Quarter | # | Revenue | PBT | NP | NP to SH | Div | Net Worth | Div Payout % | NP Margin | ROE | NOSH | RPS | Adj. RPS | EPS | Adj. EPS | DPS | Adj. DPS | NAPS | Adj. NAPS | QoQ | YoY | EOQ Date | EOQ Price | EOQ P/RPS | EOQ P/EPS | EOQ P/NAPS | EOQ EY | EOQ DY | ANN Date | ANN Price | ANN P/RPS | ANN P/EPS | ANN P/NAPS | ANN EY | ANN DY |
PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.
NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.
Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.
All figures in '000 unless specified.
Discussions
19 people like this. Showing 50 of 16,157 comments
Yeah. Good analysis. Expect it to go up and down from day traders. By the 4 years end, China glove manufacturers could had been battered badly for Malaysian manufacturers to thrive even longer.
2 weeks ago
Why IB never told u that China will set up factory at cheaper countries to bypass tariff ??? Try imagine what will happen to malaysia glove if they announce this step !
2 weeks ago
Yesterday here maths +0.42 (22.95%)
Today here -0.18 (8.00%)
Still profit 0.24 Sen
Mana rugi using maths
2 weeks ago
In Harta forum is already told you US target China manufacturers even if their products come from Mexico or Indonesia. And here you are again talking BS.
NatsukoMishima
Why IB never told u that China will set up factory at cheaper countries to bypass tariff ??? Try imagine what will happen to malaysia glove if they announce this step !
2 weeks ago
This nut modus operandi is he has unloaded his holdings then will go to every glove forum to spread negativity to create fear to push down the price so that he can load the holdings again and repeat the action
2 weeks ago
With Kossan securing good earnings in coming years, I'm pretty sure they can reward good dividend too from the Rm2bill holdings.
2 weeks ago
Nut psycho favourite thing to do is promote his highly speculative counters and talk rubbish about stocks he doesn't hold. He loves mocking others especially when they are losing money.
2 weeks ago
Let day traders clear their holdings. Long term investors can hold until Q125 to see the effect of the tariff.
Q3 & Q4 2024 is pretty much irrelevant.
2 weeks ago
"Attractive Dividend policy"? Hahaha.... Hartalega only recently give dividend since their last dividend in 2022.
Kossan has been constantly giving dividend. Sell your Hartalega and buy Kossan. Kossan should be same value as Hartalega.
WDCQ_I_am_legend
https://youtu.be/tkuYRBsxxxA
2 weeks ago
Republican U.S. Senator Marco Rubio on Thursday proposed barring Chinese manufacturers from evading tariffs by setting up factories in other countries like Mexico, Vietnam or Malaysia.
Rubio accused Chinese manufacturers of shifting production to other countries that face lower U.S. tariffs, saying it allowed them "to evade tariffs and flood the U.S. market with cheap goods." A House committee raised concerns last week about a Chinese auto parts firm that may have sought to evade tariffs.
2 weeks ago
Yeah. Harta subsidiary in India mislabel their chlorinated latex glove as non-chlorinated and sold to hospitals at cheaper price. It's really about money and tax I think. Don't think shithole of a country like India cares about the environment.
https://www.medicalbuyer.co.in/hartalega-supplies-banned-chlorinated-gloves-through-mun-health-product/
1 week ago
Ok... I read the Indian article again and finally straighten things out. Typical India talking pusing pusing. ...
Mun Health (buyer in India) imports non-medical gloves (chlorinated) and sell them to hospitals at cheaper price. Bcoz non-medical gloves are cheaper. Mun Health is undercutting other suppliers in India by cheating. Mun Health should be punished instead of banning Harta. Has nothing to do with Harta. Harta just sells what is ordered by Mun Health. Mun Health gets Harta to OEM the glove under "Glove-On Eureka" brand.
This Indian article talk about mislabelling la for the port of entry bla bla bla .... purposely declare as non-medical so no need to submit certification la just to blame Harta ... wahlau... .
1 week ago
The U.S. government announced a sharp increase in tariffs on Chinese surgical gloves, raising rates to 50% for 2025 and 100% for 2026F.
The final modification imposes a much steeper tariff, which will significantly increase Chinese average selling prices (ASPs) to US$25.50/1K pcs by 2025 and US$34/1K pcs by 2026, from the current ASP of US$17/1K pcs. Given that Malaysian manufacturers' blended ASPs of US$19-21/1K pcs currently, Chinese ASPs are expected to exceed those of Malaysian producers by 21%-34% as early as next year. Hence, the reversal of the current price gap between Chinese and Malaysian gloves would enhance the competitive position of Malaysian players.
Remark: Kossan export about 45-50% of its glove to US market
1 week ago
The impact on USD weakness is mitigated by fact that 40% of glove manufacture cost are also denominated in USD.
The remain negative impact on USD weakness can easily offset entirely by increase glove ASP which have big room of hike in 2025 by 20% from current US$19-21/1K pcs to US$25.50/1K pcs by 2025 to match Chinese glove and further 40% hike ASP potential US$34/1K pcs by 2026 match Chinese glove.
Glove profitability in USD= ASP hike + globve volume sold - (feedcost in USD)
Remark: The impact on USD weakness is NOT only affect Msia glove manufacture, but also affect Thai and China glove manufacture.
USD weakness by 12.5% in RM
USD weakness by 10.9% in Thai bath
USD weakness by 3.5% in Chinese Yuan
Therefore, all top 3 top global glove maker will collectively demand ASP hike to offset USD weakness
1 week ago
With tumbling in crude oil price now, glove maker energy cost and major raw material cost, nitrile butadiene will decrease substantially. Both energy and raw material collectively form 20% and 30% respectively, input cost in glove manufacturing. Raw material cost is denominator in USD, offer natural hedge again weak USD
Incoming US traffic 50% surcharge on competitor China glove will prompt Msia hike ASP more than offset weakness in USD. This tariff move removes the underutilization of glove makers with a very high margin. Profits are coming back
1 week ago
Based on The Office of the United States Trade Representative (USTR) announced final modifications concerning the statutory review of the tariff actions in the Section 301 investigation of the People's Republic of China's (PRC) Acts, Aside Medical Gloves. Increase rate to 50 percent in 2025 and 100 percent in 2026.
Another glove manufacture product, facemask also impose tax increament. Face Masks. Increase rate to 25 percent in 2025 and 50 percent in 2026.
1 week ago
Foreign worker wage if increase, glove maker can easily adopt cost pass through as there is BIG room for ASP hike to UP begin next year to compete China glove after 50% tax hike and following year 100% tax hike for China glove
In additional, cost production will also decrease due to tumbling crude oil, a main raw material for nitrile butadiene and energy cost, offset wages increase
1 week ago
Take note, current Malaysia glove main threat is competition from China which force Malaysia glove ,anmaufacture to halt ASP hike and decrease plant utilization rate to 35%.
Therefore, once US Tax enforce 50% on China glove in next year and 100% tax next on 2026, Malaysia glove maker will regain back glove market share in US
1 week ago
Msia is killing our own economy. Hiking foreign pay will syphon our money into their country. And at 2K/month, this foreign workers don't pay tax although there's levies paid but paid by employers. Increasing foreign pay will not encourage employers to hire locals instead bcoz locals don't want the job to begin with.
1 week ago
Agreed. If minimum wage pass, many EMS and semiconductor industries will suffer as they can't pass cost through due to fixed orderbook price
Construction and properties sector also suffer, increase project cost and hike properties selling price is inevitable which will result low demand
For glove manufacture, situation is bit different due to policy anti-China glove product, a massive hike of 50% tax in 2025 and 100% hike in 2026 will give huge room for Malaysia to capitalize with huge ASP hike forward and increase volume loaded and higher plant utilization.
In additional, crude oil slump resulted cheaper raw material nitrile butadiene will give higher profit margin forward
1 week ago
Then we should see better result in Q3. Nat gas and oil prices are down. Q4 we should see more order coming from US. They might avoid China fearing their cargo may arrive in 2025.
1 week ago
More importantly is promising outlook, both in 2025 and 2026 when major competitor suffers 50% and 100% tax levy given Msia glove maker ample room to hike ASP and increase current loss making depress 35% plant utilization rate for next 2 year forward.
1 week ago
dompeilee
Posted by dompeilee > 2024-01-08 08:48
I didn't manage to buy Kossan @ $1 BUT my last purchases were @ $1.2932, $1.2767 & $1.384 in June & July 2022 which more than doubled my earlier stake & lowered my average to $1.8003 & earned $322.75 in dividends to boot!🤗
After selling most of my Kossan a little too early in Jan & Mar, I SOLD 80% of my remaining stake @ $2.25 this morning.
1 week ago
Ahhh...satisfying!!!☝ Got chance to re-average down again closer to 2025!
1 week ago
Topglove highlight
1. The Group is optimistic that the strong growth momentum will sustain, as customers continue replenishing their depleting glove stockpiles. The group continues to see MoM uptrend in sales volume in Sept 2024 and expects customers’ replenishment activity to pick up in subsequent quarters, underpinned by inventory rebuilding by distributors, indicating that demand recovery had further gained momentum. Presently, its sales volume had strengthened 25%-30% MoM, bringing utilisation rate to 65%-70% vs. our assumption of 55% in FY25 (based on 64b pieces capacity) compared to 45% in 3QFY24. Recall, it has previously highlighted that the bulk of a shipment delay in 3QFY24 estimated at 500m pieces had already been shipped and will be booked in 4QFY24.
2. It is optimistic that ASPs are expected to inch up gradually, potentially by 5%-15% or USD0.80 - USD1.50 per 1,000 pieces due to the uptick in demand and mitigation against the appreciating MYR against USD. However, due to the lag impact, ASP increases will only be felt gradually starting from Nov-Dec CY24. We believe predatory pricing by certain overseas players (i.e. selling below cost over an extended period to eliminate competition) have diminished as Chinese players’ utilization hit >90% While TOPGLOV is silent on existing ASP, we estimate every USD1 change impacts earnings by below 2%. We conservatively assumed ASP of USD20/1,000 pieces in our earnings model.
3. The group highlight that its exports to the US is continuing to show improvement which currently accounts for 28%-30% of its geographical sales mix. As an indication, TOPGLOV has seen its volume sales from the US market raising 20% YoY to account for 15% in 9MFY24 compared to pre-pandemic average of 20%-30%.
1 week ago
Thank you for the information and objectivity. Next 2 qtrs will have to be great if all the finincials estimates are accurate
1 week ago
healthcare services are often considered defensive, increase volume sold, plant utilisation and ASP hike are main catalyst to propel earning recovery back to prepademic earning.
6 days ago
Fed Chair Jerome Powell hinted the central bank is not in a rush to rapidly cut rates.
Better invest in defensive healthcare related stock, glove is essential and stiff China competition is easing due to upcoming 50% tax levy in 2025 and 100% tax levy in 2026
6 days ago
Bargain Hartalega & Kossan
Hartalega will need convincing strength above the 100-day ma (RM3.06) to fuel further upside towards RM3.30, the 123.6%FP (RM3.43) and 138.2%FP (RM3.68) ahead, while downside risk is capped by the 76.4%FR (RM2.66). Kossan need a confirmed breakout above the 200-day ma (RM2.06) to enhance upside momentum towards the 100-day ma (RM2.19), RM2.33 and 123.6%FP (RM2.42) going forward, while the 61.8%FR (RM1.79) and lower Bollinger band (RM1.71) cushions downside.
6 days ago
Indications are pointing to a strong demand recovery moving into 4QCY24 and CY25 that will exceed our previous assumptions, underpinned by inventory rebuilding from distributors. Specifically, there has been uptick in orders over the past two quarters. The rise in demand comes as the inventories of major distributors across all regions have returned to normal levels. Case in point - HARTA expects to hit sales volume of 2.2b pieces/month in 2HFY25. Already, HARTA has seen 1QFY25 orders hitting close to 2b pieces per month compared to 1.5b-1.8b pieces per month in 4QFY24 and 3QFY23. TOPGLOV is optimistic that the strong growth momentum will sustain, as customers continue replenishing their depleting glove stockpiles. The group continues to see MoM uptrend in sales volume in June 2024 and expect customers’ replenishment activity to pick up in subsequent quarters, underpinned by inventory rebuilding from distributors, indicating early signs of potential recovery in demand. It has seen sales order rising 25%-30% MoM. Tell-tale signs of predatory pricing by certain overseas players (i.e. selling below cost over an extended period of time to eliminate competitors) have diminished. Specifically, glove players under our coverage have seen their ASPs rising over the past two quarters, potentially implying demand is on the path to a recovery boosted by order replenishment.
4 days ago
USD strength further to RM 4.27 due to global tension and fed hint no rush to cut rate
1 day ago
Malaysia’s gloves export volume surged 66% MoM and 105% YoY in Aug, outpacing the growth in July (+12% MoM; +43% YoY). The latest export volume is even 34% higher compare to pre-pandemic 2-years monthly average number indicating that the recovery momentum of global gloves demand remains healthy.
23 hours ago
Post a Comment
Featured Posts
Latest Videos
Apps
Top Articles
1
2
3
4
5
6
TA Sector Research
Weekly Strategy - External Uncertainties Could Sustain Downside Pressure
7
Stock Market Enthusiast
8
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
KimSua
Ustr is a 4 Yr review cycle but one analyst mentioned 2 and down play the news. I suspect Trump to win and seal this until end 2028. China will not be able to continue to subsidize glove industry and retarget their focus. ASP will continue to rise and allow US manufacturers to start production, by then Malaysian glove industry will have a windfall in the next 4 yrs years at least. Let's see how is the profit taking today and see how foreign funds read the news.
2 weeks ago